Chungcheongbuk-do, South Korea

Sena Kim


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sena Kim - Innovator in Pharmaceutical Composition

Introduction

Sena Kim is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of inflammatory diseases. His innovative approach has led to the development of a unique pharmaceutical composition that showcases his expertise and dedication to improving healthcare.

Latest Patents

Sena Kim holds 1 patent related to a pharmaceutical composition for treating and preventing inflammatory diseases. This invention involves an ethyl acetate fraction of dried extract as an active ingredient. The composition is refined and concentrated to contain 0.05 to 12% by weight of arctigenin, which serves as an index material. This innovative method for producing the fraction highlights his commitment to advancing medical treatments.

Career Highlights

Sena Kim is currently associated with Shin-il Pharmaceutical Co., Ltd., where he continues to work on groundbreaking pharmaceutical innovations. His career is marked by a focus on developing effective treatments that address pressing health issues. His work has the potential to significantly impact the pharmaceutical industry and improve patient outcomes.

Collaborations

Sena Kim collaborates with talented individuals in his field, including Jeong Min Lee and Jee Hun Park. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Sena Kim's contributions to pharmaceutical innovation demonstrate his commitment to improving healthcare through research and development. His work in creating effective treatments for inflammatory diseases is a testament to his skills as an inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…